Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll-Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study.

afimetoran (BMS-986256) - BMS

http://www.ncbi.nlm.nih.gov/pubmed/40568766

Fareeda Hosein; Frédéric Baribaud; Gopal Krishna; Hazem Karabeber; Jasmine Saini; Kristina D Chadwick; Leonidas N Carayannopoulos; Lin Zhu; Melanie Harrison; Michelle Dawes; Stanislav Ignatenko; Thanh Bach; Urvi Aras; Wanying Zhang

Jun 26, 2025